drugset / Trial / NCT03030911

Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients

NCT03030911 ↗

Phase 4 Completed 30 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to compare the effect of dexmedetomidine on resting energy expenditure in relation to the midazolam in critically ill patients using indirect calorimetry

Timeline

Start
2017-01-01
Primary completion
2018-03-10
Completion
2018-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.75 ug/kg —
Comparator Midazolam Small molecule 5 mg —
Comparator Fentanyl Other / unclassified 1 ug/kg —

Indications

No indication recorded.